Fibrinogen and aging

Aging Clinical and Experimental Research

Volumn 6, Issue 2, 1994, Pages 133-138

  Hager, K ^a,b   Felicetti, M ^a   Seefried, G ^a   Platt, D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Clinic for Medical Rehabilitation and Geriatrics   (Germany)

Author keywords

Aging; cardiovascular risk factors; fibrinogen; fibrinogen D dimers

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROSPECTIVE STUDIES;

EID: 0028673190     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03324226     Document Type: Article

References (29)

1. Fibrinogen as a risk factor for stroke and myocardial infarction
2. Plasma fibrinogen — a major coronary risk factor
3. Haemostatic function and ischaemic heart disease: Principal results of the North-wick Park Heart Study
4. Fibrinogen and risk of cardiovascular disease. The Framingham Study
5. Predictive value of haemostatic variables in the PROCAM-study
6. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies
7. The relationship to age and cerebral vascular accidents of fibrin and fibrinolytic activity
8. Blood coagulation, fibrinolysis and platelet function in women aged 38, 46, 50, 54 and 60. The study of women in Gothenburg 1968–1969
9. The effect of age upon the coagulation system
10. Plasma fibrinogen levels in 1,016 regular blood donors. I. The influence of age and sex on mean values and percentiles
11. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age
12. Hemorheological changes in elderly subjects — effect of pentosan polysulfate and possible role of leucocyte arachidonic acid metabolism
13. Hämorheologie im Alter
14. Thrombocyte functions, thrombelastograms and fibrinogen of healthy children in different age groups
15. Development of the hemostatic system in the neonate and young infant
16. Seasonal variations in fibrinogen concentrations among elderly people
17. Regional variations in plasma fibrinogen levels
18. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
19. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience
20. Correlations of the fibrinogen level with blood pressure and with the plasma renin activity in hypertensive patients
21. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
22. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study
23. Blood coagulation factors in the elderly
24. 131I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa
25. Fibrinogen metabolism following injury and its surgical treatment
26. The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells
27. Epidermal growth factor and transforming growth factor-ß differently modulate the acute phase response elicited by interleukin-6 in cultured liver cells from man, rat and mouse
28. Interleukin-6: A cytokine for Gerontologists